UPDATE: Goldman Sachs Resumes Coverage on Plexus on Margin and ROIC Upside

In a report published Wednesday, Goldman Sachs analyst Mark Delaney resumed coverage on Plexus Corp. PLXS with a Buy rating and $42.00 price target. In the report, Goldman Sachs noted, “We resume coverage of Plexus with a Buy rating and a 6-month price target of $42 (12% upside). Plexus has lagged EMS peers (it is up 24% yoy vs. the peer average of up 61% yoy), likely driven by its announcement in November 2012 that its historically largest customer Juniper (16% of revenue) was leaving to consolidate with fewer suppliers. In addition, sales to Coke (formerly a large customer) have been well below prior levels due to weak sell-through of the Coke freestyle machine. We believe this creates an opportunity. (1) Plexus's revenue growth profile is de-risked, and it now has about 70% of sales tied to high-mix end markets. (2) We expect Plexus to expand margins and ROIC in 2014 due to the increased percentage of high-mix business and reduced capex on facility consolidations. (3) We believe Plexus is a potential M&A candidate given its exposure to high-mix markets where its larger competitors have been doing M&A.” Plexus Corp. closed on Tuesday at $37.66.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorInitiationAnalyst RatingsGoldman SachsMark Delaney
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!